Persistent URL of this record https://hdl.handle.net/1887/3248780
In Collections
This item can be found in the following collections:
![Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement
- All authors
- Mellion, M.L.; Ronco, L.; Berends, C.L.; Pagan, L.; Brooks, S.; Esdonk, M.J. van; Brummelen, E.M.J. van; Odueyungbo, A.; Thompson, L.A.; Hage, M.; Badrising, U.A.; Raines, S.; Tracewell, W.G.; Engelen, B. van; Cadavid, D.; Groeneveld, G.J.
- Date
- 2021-05-14
- Volume
- 87
- Issue
- 12
- Pages
- 4658 - 4669